Drug Profile
Griseofulvin topical - Transdermal
Alternative Names: GrisolLatest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Transdermal Ltd
- Class Antifungals; Benzofurans; Small molecules
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Tinea
- No development reported Onychomycosis
Most Recent Events
- 23 Jun 2001 No-Development-Reported for Onychomycosis in United Kingdom (Topical)
- 23 Jun 2001 No-Development-Reported for Tinea in Canada (Topical)
- 23 Jun 2001 No-Development-Reported for Tinea in Greece (Topical)